These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20653801)

  • 1. Cardiovascular risk evaluation and antiretroviral therapy effects in an HIV cohort: implications for clinical management: the CREATE 1 study.
    Aboud M; Elgalib A; Pomeroy L; Panayiotakopoulos G; Skopelitis E; Kulasegaram R; Dimian C; C Lampe F; Duncan A; Wierzbicki AS; Peters BS
    Int J Clin Pract; 2010 Aug; 64(9):1252-9. PubMed ID: 20653801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular risk factors among Ghanaian patients with HIV: A cross-sectional study.
    Appiah LT; Sarfo FS; Huffman MD; Nguah SB; Stiles JK
    Clin Cardiol; 2019 Dec; 42(12):1195-1201. PubMed ID: 31571256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rates of cardiovascular disease following smoking cessation in patients with HIV infection: results from the D:A:D study(*).
    Petoumenos K; Worm S; Reiss P; de Wit S; d'Arminio Monforte A; Sabin C; Friis-Møller N; Weber R; Mercie P; Pradier C; El-Sadr W; Kirk O; Lundgren J; Law M;
    HIV Med; 2011 Aug; 12(7):412-21. PubMed ID: 21251183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-sensitivity C-reactive protein among people living with HIV on highly active antiretroviral therapy: a systemic review and meta-analysis.
    Mabhida SE; Mchiza ZJ; Mokgalaboni K; Hanser S; Choshi J; Mokoena H; Ziqubu K; Masilela C; Nkambule BB; Ndwandwe DE; Kengne AP; Dludla PV
    BMC Infect Dis; 2024 Feb; 24(1):160. PubMed ID: 38308222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors and assessment for cardiovascular disease among HIV-positive patients attending a Nigerian tertiary hospital.
    Osegbe ID; Soriyan OO; Ogbenna AA; Okpara HC; Azinge EC
    Pan Afr Med J; 2016; 23():206. PubMed ID: 27347295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active antiretroviral therapy.
    Moerman F; Van Gompel A; Nimmegeers J; Moerman J
    BMJ; 2005 Jun; 330(7504):1341-2. PubMed ID: 15947375
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular Disease Risk Assessment: Insights from Framingham.
    D'Agostino RB; Pencina MJ; Massaro JM; Coady S
    Glob Heart; 2013 Mar; 8(1):11-23. PubMed ID: 23750335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of traditional cardiovascular risk factors and evaluation of cardiovascular risk using three risk equations in nigerians living with human immunodeficiency virus.
    Edward AO; Oladayo AA; Omolola AS; Adetiloye AA; Adedayo PA
    N Am J Med Sci; 2013 Dec; 5(12):680-8. PubMed ID: 24404550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pitavastatin in the Prevention of Cardiovascular Disease in People Living with HIV: A Review.
    Whiteson HZ; Drogy M; Eickel G; Frishman WH
    Cardiol Rev; 2024 Jan; ():. PubMed ID: 38294226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of high-sensitivity C-reactive protein measurements in HIV patients.
    Vishwanath A; Quaiser S; Khan R
    Indian J Sex Transm Dis AIDS; 2016; 37(2):123-128. PubMed ID: 27890944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities in women living with HIV: A systematic review.
    Raffe S; Sabin C; Gilleece Y;
    HIV Med; 2022 Apr; 23(4):331-361. PubMed ID: 35243744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of cardiovascular disease risks using Framingham risk scores (FRS) in HIV-positive and HIV-negative older adults in South Africa.
    Nyirenda M
    Prev Med Rep; 2021 Jun; 22():101352. PubMed ID: 33816089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of cardiometabolic syndrome in HIV-infected persons: a systematic review.
    Woldu M; Minzi O; Engidawork E
    J Diabetes Metab Disord; 2020 Dec; 19(2):1671-1683. PubMed ID: 33553042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving translational research in sex-specific effects of comorbidities and risk factors in ischaemic heart disease and cardioprotection: position paper and recommendations of the ESC Working Group on Cellular Biology of the Heart.
    Perrino C; Ferdinandy P; Bøtker HE; Brundel BJJM; Collins P; Davidson SM; den Ruijter HM; Engel FB; Gerdts E; Girao H; Gyöngyösi M; Hausenloy DJ; Lecour S; Madonna R; Marber M; Murphy E; Pesce M; Regitz-Zagrosek V; Sluijter JPG; Steffens S; Gollmann-Tepeköylü C; Van Laake LW; Van Linthout S; Schulz R; Ytrehus K
    Cardiovasc Res; 2021 Jan; 117(2):367-385. PubMed ID: 32484892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between lipodystrophy and length of exposure to ARTs in adult HIV-1 infected patients in Montreal.
    Alikhani A; Morin H; Matte S; Alikhani P; Tremblay C; Durand M
    BMC Infect Dis; 2019 Sep; 19(1):820. PubMed ID: 31533648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in cardiovascular risk and clinical outcomes in a HIV/AIDS cohort study over a 1-year period at a specialized clinic in Mexico.
    Cibrián-Ponce A; Sánchez-Alemán MA; García-Jiménez S; Pérez-Martínez E; Bernal-Fernández G; Castañon-Mayo M; Ávila-Jiménez L; Toledano-Jaimes CD
    Ther Clin Risk Manag; 2018; 14():1757-1764. PubMed ID: 30288045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteoporosis in Human Immunodeficiency Virus Patients - An Emerging Clinical Concern.
    Maffezzoni F; Porcelli T; Karamouzis I; Quiros-Roldan E; Castelli F; Mazziotti G; Giustina A
    Eur Endocrinol; 2014 Feb; 10(1):79-83. PubMed ID: 29872469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study.
    Duncan AD; Goff LM; Peters BS
    PLoS One; 2018; 13(3):e0194199. PubMed ID: 29529066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing and Refining Myocardial Infarction Risk Estimation Among Patients With Human Immunodeficiency Virus: A Study by the Centers for AIDS Research Network of Integrated Clinical Systems.
    Feinstein MJ; Nance RM; Drozd DR; Ning H; Delaney JA; Heckbert SR; Budoff MJ; Mathews WC; Kitahata MM; Saag MS; Eron JJ; Moore RD; Achenbach CJ; Lloyd-Jones DM; Crane HM
    JAMA Cardiol; 2017 Feb; 2(2):155-162. PubMed ID: 28002550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sex Differences in Tobacco Use Among Persons Living With HIV/AIDS: A Systematic Review and Meta-Analysis.
    Weinberger AH; Smith PH; Funk AP; Rabin S; Shuter J
    J Acquir Immune Defic Syndr; 2017 Apr; 74(4):439-453. PubMed ID: 28002182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.